Ongoing global surveillance by the WHO and CDC shows no novel pathogen with sustained human-to-human transmission capable of triggering a pandemic in 2026, underpinning the 94% market-implied odds for "No." Regional outbreaks, including the Bundibugyo Ebola virus disease in the DRC and Uganda that prompted a PHEIC declaration, remain contained without evidence of efficient airborne spread or immune evasion enabling worldwide escalation. Sporadic zoonotic events such as avian influenza H5N1 and hantavirus cases have not produced the rapid, exponential growth seen in prior pandemics. Trader consensus reflects this low baseline risk from current epidemiological data, though an unexpected viral mutation or undetected Disease X emergence could still alter trajectories before year-end.